Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of Suppressive Myeloid Cell Enrichment with Aggressive Oropharynx Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 37190274 | PubTator, text mining | PubMed |
| Mannose Inhibits the Pentose Phosphate Pathway in Colorectal Cancer and Enhances Sensitivity to 5-Fluorouracil Therapy. | Cancers (Basel) | 2023 | 37190196 | PubTator, text mining | PubMed |
| Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer. | ESMO Open | 2023 | 37178669 | PubTator, text mining | PubMed |
| Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck. | Cancers (Basel) | 2023 | 37173898 | PubTator, text mining | PubMed |
| Digital twin concept: Healthcare, education, research. | J Pathol Inform | 2023 | 37168801 | PubTator, text mining | PubMed |
| Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository. | Clin Pharmacol Ther | 2023 | 37163252 | PubTator, text mining | PubMed |
| A Case of Acute Encephalopathy After the Initiation of FOLFOX Chemotherapy in a Patient With Colon Cancer. | Cureus | 2023 | 37162780 | PubTator, text mining | PubMed |
| Advanced statistics identification of participant and treatment predictors associated with severe adverse effects induced by fluoropyrimidine-based chemotherapy. | Cancer Chemother Pharmacol | 2023 | 37162533 | PubTator, text mining | PubMed |
| Reply to "Implementation of DPYD Genotyping in Admixed American Populations: Brazil as a Model Case". | Clin Pharmacol Ther | 2023 | 37161580 | PubTator, text mining | PubMed |
| Implementation of DPYD Genotyping in Admixed American Populations: Brazil as a Model Case. | Clin Pharmacol Ther | 2023 | 37161547 | PubTator, text mining | PubMed |
| Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer. | World J Gastroenterol | 2023 | 37155531 | PubTator, text mining | PubMed |
| Clinical outcomes of chemotherapy in cancer patients with different ethnicities. | Cancer Rep (Hoboken) | 2023 | 37150853 | PubTator, text mining | PubMed |
| SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022). | Clin Transl Oncol | 2023 | 37148499 | PubTator, text mining | PubMed |
| [Translated article] Genetic variants and enzyme activity in citidin deaminase: Relationship with capecitabine toxicity and recommendation for dose adjustment. | Farm Hosp | 2023 | 37147242 | PubTator, text mining | PubMed |
| Advanced prodrug strategies in nucleoside analogues targeting the treatment of gastrointestinal malignancies. | Front Cell Dev Biol | 2023 | 37143892 | PubTator, text mining | PubMed |
| Prodrug Strategies for the Development of β-l-5-((E)-2-Bromovinyl)-1-((2S,4S)-2-(hydroxymethyl)-1,3-(dioxolane-4-yl))uracil (l-BHDU) against Varicella Zoster Virus (VZV). | J Med Chem | 2023 | 37140467 | PubTator, text mining | PubMed |
| Epidural stimulation restores muscle synergies by modulating neural drives in participants with sensorimotor complete spinal cord injuries. | J Neuroeng Rehabil | 2023 | 37138361 | PubTator, text mining | PubMed |
| SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022). | Clin Transl Oncol | 2023 | 37133732 | PubTator, text mining | PubMed |
| Unlocking Genetic Profiles with a Programmable DNA-Powered Decoding Circuit. | Adv Sci (Weinh) | 2023 | 37116171 | PubTator, text mining | PubMed |
| Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist's Perspective. | Cancer Control | 2023 | 37115533 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=27